# ZIPRASIDONE MESYLATE

NDC: 51662-1564
Generic name: ZIPRASIDONE MESYLATE
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAMUSCULAR
Marketing started: 20210717

FDA application: ANDA211908

## Active ingredients

- ZIPRASIDONE MESYLATE: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1564"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1564
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c75971f8-9640-a6e8-e053-2995a90af654